IBO today
$4.77+$0.47 (+10.93%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBearish
5 minLeaning Bullish
Daily trend turns up above $277.89
Key levels
Resistance$276.13
Resistance$272.97
Latest news & SEC filings
SEC FilingImpact Biomedical Inc. filed an insider trading report (Form 4)
All IBO news →About Impact BioMedical
Impact BioMedical discovers, patents, and develops biotech and wellness technologies, partnering with outside companies to license and commercialize them. Its main programs include Linebacker for oncology and inflammatory conditions, Laetose as an alternative sugar, 3F functional fragrance formulations, and Equivir antiviral polyphenol blends. It operates through subsidiaries such as Global BioLife, Impact BioLife Science, Global BioMedical, and Sweet Sense, targeting pharmaceutical, food, and consumer packaged goods partners worldwide.
Based on the company's 10-K filed Mar 11, 2026.
NYSE · Healthcare
IMPACT BIOMEDICAL INC. (IBO)
What Is the Price Target for IBO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is IBO a Buy or Sell Right Now?
Thesis
- •Revenue growing -36.0% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IBO.
Start Free Trial →Is IBO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$31.08
17
Moat Score
NONE
5/9
Piotroski Score
37.1
Altman Z-Score
What Is Smart Money Doing with IBO?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chan Heng Fai Ambrose | director 10% owner | Sale | 4,170 | $19K | Oct 7, 2026 |
| Grady Jason | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| Macko Todd D | officer | Sale | 4,170 | $19K | Oct 7, 2026 |
| Suseck Mark | officer | Sale | 4,170 | $19K | Oct 7, 2026 |
| Zimmerman Christian Thomas | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| Hibbert Castel Berisford | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| Sims Melissa Kaye | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| Keene David K | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| Brownell Elise | director | Sale | 4,170 | $19K | Oct 7, 2026 |
| DSS, INC. | 10% owner | Sale | 156 | $1K | Sep 24, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IBO Growth Story
Revenue YoY
-36.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
83.48%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for IBO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IBO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:07:18 | $3.85 | 1,000 | $$4K | SELL |
| 19:56:19 | $4.11 | 1,000 | $$4K | BUY |
| 19:55:51 | $4.12 | 1,600 | $$7K | BUY |
| 14:35:40 | $3.08 | 1,000 | $$3K | BUY |
| 13:52:26 | $2.69 | 1,000 | $$3K | SELL |
5 dark pool trades shown · $$20K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About IBO
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for IBO. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $IBO — DSS, INC. | Sale $1K $STKS — HILARIO EMANUEL N | Sale $18K $ONDS — LAIRD NEIL J | Sale $ONDS — LAIRD NEIL J | Sale $38K $CMPX — Lerner Neil | Sale $3K
Join 3,500+ traders discussing IBO in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for IMPACT BIOMEDICAL INC. (IBO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (9 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IBO — frequently asked questions
What is IBO stock price today?
IMPACT BIOMEDICAL INC. (IBO) is at $4.77, up 10.93% (+$0.47) at the Nov 12, 2026 close.
Why is IBO stock moving today?
Latest IBO news — Nov 5, 2026: Impact Biomedical Inc. filed an insider trading report (Form 4)
Did IBO beat earnings?
IBO last reported on Aug 7, 2026: EPS -$0.13.
What is IBO's P/E ratio?
IBO trades at a P/E of 4.9 vs a Healthcare average of 17.1.
Does IBO pay a dividend?
IBO does not currently pay a dividend.
What are IBO support and resistance levels?
Resistance: $272.97, $276.13, $277.89.
What are insiders doing with IBO?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on IBO?
Nov 5, 2026: Impact Biomedical Inc. filed an insider trading report (Form 4)